112 related articles for article (PubMed ID: 10327383)
21. The effects of yohimbine plus L-arginine glutamate on sexual arousal in postmenopausal women with sexual arousal disorder.
Meston CM; Worcel M
Arch Sex Behav; 2002 Aug; 31(4):323-32. PubMed ID: 12187545
[TBL] [Abstract][Full Text] [Related]
22. Oral contraceptive use and female genital arousal: methodological considerations.
Seal BN; Brotto LA; Gorzalka BB
J Sex Res; 2005 Aug; 42(3):249-58. PubMed ID: 19817038
[TBL] [Abstract][Full Text] [Related]
23. Treating symptoms of female sexual arousal disorder with the Eros-Clitoral Therapy Device.
Wilson SK; Delk JR; Billups KL
J Gend Specif Med; 2001; 4(2):54-8. PubMed ID: 11480099
[TBL] [Abstract][Full Text] [Related]
24. Sexual dysfunction in the peri- and postmenopause. Status of incidence, pharmacological treatment and possible risks. A secondary publication.
Gregersen N; Jensen PT; Giraldi AE
Dan Med Bull; 2006 Aug; 53(3):349-53. PubMed ID: 17092454
[TBL] [Abstract][Full Text] [Related]
25. A phase 2a multicenter, double-blind, placebo-controlled, crossover trial to investigate the efficacy, safety, and toleration of CP-866,087 (a high-affinity mu-opioid receptor antagonist) in premenopausal women diagnosed with female sexual arousal disorder (FSAD).
Orri M; Abraham L; Giraldi A
J Sex Med; 2013 Oct; 10(10):2484-96. PubMed ID: 23347610
[TBL] [Abstract][Full Text] [Related]
26. The effects of false positive and false negative physiological feedback on sexual arousal: a comparison of women with or without sexual arousal disorder.
McCall KM; Meston CM
Arch Sex Behav; 2007 Aug; 36(4):518-30. PubMed ID: 17333325
[TBL] [Abstract][Full Text] [Related]
27. Objective assessment of sexual arousal in women with a history of hysterectomy.
Maas CP; ter Kuile MM; Laan E; Tuijnman CC; Weijenborg PT; Trimbos JB; Kenter GG
BJOG; 2004 May; 111(5):456-62. PubMed ID: 15104610
[TBL] [Abstract][Full Text] [Related]
28. Treatment with percutanous testosterone gel in postmenopausal women with decreased libido--effects on sexuality and psychological general well-being.
Nathorst-Böös J; Flöter A; Jarkander-Rolff M; Carlström K; Schoultz Bv
Maturitas; 2006 Jan; 53(1):11-8. PubMed ID: 16183220
[TBL] [Abstract][Full Text] [Related]
29. The female sexual function index (FSFI): cross-validation and development of clinical cutoff scores.
Wiegel M; Meston C; Rosen R
J Sex Marital Ther; 2005; 31(1):1-20. PubMed ID: 15841702
[TBL] [Abstract][Full Text] [Related]
30. Oral phentolamine: an alpha-1, alpha-2 adrenergic antagonist for the treatment of erectile dysfunction.
Goldstein I
Int J Impot Res; 2000 Mar; 12 Suppl 1():S75-80. PubMed ID: 10845768
[TBL] [Abstract][Full Text] [Related]
31. Vulvovaginal atrophy is strongly associated with female sexual dysfunction among sexually active postmenopausal women.
Levine KB; Williams RE; Hartmann KE
Menopause; 2008; 15(4 Pt 1):661-6. PubMed ID: 18698279
[TBL] [Abstract][Full Text] [Related]
32. Acute dehydroepiandrosterone (DHEA) effects on sexual arousal in postmenopausal women.
Hackbert L; Heiman JR
J Womens Health Gend Based Med; 2002 Mar; 11(2):155-62. PubMed ID: 11975863
[TBL] [Abstract][Full Text] [Related]
33. Testosterone therapy in women: a review.
Bolour S; Braunstein G
Int J Impot Res; 2005; 17(5):399-408. PubMed ID: 15889125
[TBL] [Abstract][Full Text] [Related]
34. Efficacy and safety of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled trial.
Davis SR; van der Mooren MJ; van Lunsen RH; Lopes P; Ribot C; Rees M; Moufarege A; Rodenberg C; Buch A; Purdie DW
Menopause; 2006; 13(3):387-96. PubMed ID: 16735935
[TBL] [Abstract][Full Text] [Related]
35. Effect of different preparations of hormone therapy on sexual dysfunction in naturally postmenopausal women.
Osmanağaoğlu MA; Atasaral T; Baltaci D; Bozkaya H
Climacteric; 2006 Dec; 9(6):464-72. PubMed ID: 17085380
[TBL] [Abstract][Full Text] [Related]
36. Effects of bazedoxifene/conjugated estrogens on quality of life in postmenopausal women with symptoms of vulvar/vaginal atrophy.
Bachmann G; Bobula J; Mirkin S
Climacteric; 2010 Apr; 13(2):132-40. PubMed ID: 19863455
[TBL] [Abstract][Full Text] [Related]
37. The enhancement of female sexual function with ArginMax, a nutritional supplement, among women differing in menopausal status.
Ito TY; Polan ML; Whipple B; Trant AS
J Sex Marital Ther; 2006; 32(5):369-78. PubMed ID: 16959660
[TBL] [Abstract][Full Text] [Related]
38. Safety and efficacy of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled trial.
Braunstein GD; Sundwall DA; Katz M; Shifren JL; Buster JE; Simon JA; Bachman G; Aguirre OA; Lucas JD; Rodenberg C; Buch A; Watts NB
Arch Intern Med; 2005 Jul; 165(14):1582-9. PubMed ID: 16043675
[TBL] [Abstract][Full Text] [Related]
39. [Aging and sexuality in women].
Nappi RE; Albani F; Valentino V; Polatti F; Chiovato L; Genazzani AR
Minerva Ginecol; 2007 Jun; 59(3):287-98. PubMed ID: 17576405
[TBL] [Abstract][Full Text] [Related]
40. Ephedrine-activated physiological sexual arousal in women.
Meston CM; Heiman JR
Arch Gen Psychiatry; 1998 Jul; 55(7):652-6. PubMed ID: 9672057
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
